Through our pioneering research and innovation we are improving lives by giving patients the opportunity to shape and take part in clinical studies and evaluations. Click the image below to view our ...

A leading MFT cancer professor features in a documentary following TV presenter Julia Bradbury’s personal breast cancer journey.

How iTap works? iTap provides a Trust-wide framework to streamline NHS adoption of innovations that are market-ready. We match your solution with relevant clinical and operational teams, ensuring a ...

As part of a wider World Health Organisation goal to eliminate hepatitis C (a virus that can infect the liver), globally by 2030, NHS England is committed to eliminating hepatitis C by 2025. About the ...

The Biobank has been established to facilitate the conduct of high-quality biomedical research. Project examples include basic scientific research on wound healing, tissue engineering and biomarker ...

A new once-daily cystic fibrosis (CF) treatment trialled in Manchester has been approved for NHS use, following a recommendation made earlier this month by the National Institute for Health ...

Manchester University NHS Foundation Trust (MFT) has been awarded almost £2.5m to investigate the effectiveness of new airways devices to transform care and outcomes for seriously ill patients in ...

Award winning Dr Fozia Ahmed is a Consultant Cardiologist at Manchester University NHS Foundation Trust (MFT). She is also the national lead and co-chair of the Global Expert Panel for STEP HFpEF – a ...

Patients at Manchester Adult Cystic Fibrosis Centre (MACFC), based in Wythenshawe hospital – part of Manchester University NHS Foundation Trust (MFT) – are the first in Europe to have received the ...

Greater Manchester residents are being encouraged to take part in a research study at Manchester Royal Eye Hospital (MREH) that aims to improve the diagnosis and treatment of conditions associated ...

New research from Manchester University NHS Foundation Trust (MFT) and co-funded by the National Institute for Health and Care Research (NIHR) Manchester Biomedical Research Centre (BRC), has shown ...

A ground-breaking genetic test that could prevent critically ill newborn babies going deaf if treated with gentamicin, a commonly used antibiotic, is being trialled across 14 NHS neonatal (specialist ...